with RMD age <65 years who are taking immunosuppressive medication, pneumococcal vaccination is strongly recommended. Patients with RMDs taking immunosuppressive medication may be at increased risk of pneumococcal infection There are few studies evaluating the impact of diseasemodifying antirheumatic drugs (DMARDs) on conjugate pneumococcal vaccines. The ACIP recommends administering pneumococcal vaccination to individuals age >18 years with certain chronic medical conditions and those taking immunosuppressive medication Recombinant varicella-zoster virus (VZV) vaccination For patients with RMD age >18 years who are taking immunosuppressive medication, administering the recombinant VZV vaccine is strongly recommended. Patients with RMDs such as systemic lupus erythematosus (SLE) and RA are at higher risk of herpes zoster than older adults recommended for vaccination Human papillomavirus (HPV) vaccination For patients with RMD age >26 years and <45 years who are taking